2026-04-29T07:35:37Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/175682024-02-08T14:40:56Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16927
Repisalud
author
Bernal Páez, Fernando Luis
author
Alcaraz Baños, Miguel
author
Felices Abad, Jose Manuel
author
Bernal Belmonte, Ana
author
Gijon-Nogueron, Gabriel
author
Pardo Rios, Manuel
2024-02-08T14:40:56Z
2024-02-08T14:40:56Z
2018
http://hdl.handle.net/10668/13071
http://hdl.handle.net/20.500.12105/17568
30313025
10.1097/MD.0000000000012228
1536-5964
Medicine
To assess the quality of life (QoL) of treated patients in order to evaluate the success of peripheral transluminal angioplasty (PTA) and correlate physical parameters with clinical progress at 6 months post-PTA.According to TASC II classifications, 69 patients were selected for PTA. Clinical evaluation and diagnostic tests were performed before, after and after 6 months following PTA. The SF-36 QoL questionnaire was added as an additional parameter.Fifty one patients were included in the study. The ankle-brachial index (ABI) increased from 0.49 ± 0.11 before PTA, to 0.81 ± 0.14 after PTA (P
eng
Improvement of quality of life in diabetic patients treated with percutaneous transluminal angioplasty.
research article